Peptide supplier documentation, listed without the sales pitch

Valar Peptides

Selected for unusually broad public access to supplier-issued product and batch documents. This label does not mean independent laboratory verification.

U.S. manufacturing claimed; legal entity and facility location not disclosed on reviewed pages

Documentation

Public product-level COAs found on 30 of 36 catalog pages checked

Audience

Research and development customers

RUO language

The site states that all products are for research and development use only, not for human consumption, and that Valar Peptides is not a 503A/503B compounding or outsourcing facility.

Testing claims

Public product-page COAs reviewed include a batch or lot number, analysis date, HPLC identity and purity results, measured peptide quantity, endotoxin result, instrument listing, and QC authorization. The supplier separately claims mass-spectrometry confirmation and third-party verification.

Profile status: Official public batch documents reviewed

The requested valarresearch.com domain did not resolve and had no .com registry record when checked; the operating site found was valarpeptides.com. On July 10, 2026, 30 of the 36 products linked from its catalog had working public COA PDFs; AOD-9604, Hexarelin, NAD+, Oxytocin, Pinealon capsules, and Tirzepatide stated that no COA was available yet. The reviewed COAs name a Valar QC authorizer but not an independent laboratory, so they substantiate public batch documentation without independently verifying the site's third-party-testing claim. 'GMP comparable' is not evidence of GMP certification; the terms select UAE law while the site claims U.S. manufacturing.